Related references
Note: Only part of the references are listed.Astrocyte stellation, a process dependent on Rac1 is sustained by the regulated exocytosis of enlargeosomes
Gabriella Racchetti et al.
GLIA (2012)
Nrf2-dependent Induction of Proteasome and Pa28αβ Regulator Are Required for Adaptation to Oxidative Stress
Andrew M. Pickering et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Pharmacological Targeting of the Transcription Factor Nrf2 at the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism
Agnieszka Jazwa et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Stimulation of phagocytosis by sulforaphane
Hiroyuki Suganuma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease
Mickael Decressac et al.
BRAIN (2011)
Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease
Maria Cecilia Barone et al.
DISEASE MODELS & MECHANISMS (2011)
Glia: Initiators and Progressors of Pathology in Parkinson's Disease
Glenda M. Halliday et al.
MOVEMENT DISORDERS (2011)
Dopamine quinones interact with a-synuclein to form unstructured adducts
Marco Bisaglia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
Malin von Otter et al.
BMC MEDICAL GENETICS (2010)
A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
Salma Bukhatwa et al.
BRAIN RESEARCH (2010)
Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease
Shane Grealish et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Nrf2 Regulates Microglial Dynamics and Neuroinflammation in Experimental Parkinson's Disease
Ana I. Rojo et al.
GLIA (2010)
Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies
He-Jin Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract
Malin von Otter et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Vanesa Sanchez-Guajardo et al.
PLOS ONE (2010)
Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1
Nadia G. Innamorato et al.
PLOS ONE (2010)
Stress-Activated Cap'n'collar Transcription Factors in Aging and Human Disease
Gerasimos P. Sykiotis et al.
SCIENCE SIGNALING (2010)
The Pattern of Neuronal Loss and Survival May Reflect Differential Expression of Proteasome Activators in Parkinson's Disease
Kevin St. P. McNaught et al.
SYNAPSE (2010)
Role of microglial redox balance in modulation of neuroinflammation
Nadia G. Innamorato et al.
CURRENT OPINION IN NEUROLOGY (2009)
Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis
Kai-Yin Chau et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Neuroinflammation in Parkinson's Disease
Jae-Kyung Lee et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
NUCLEAR AND NEURITIC DISTRIBUTION OF SERINE-129 PHOSPHORYLATED α-SYNUCLEIN IN TRANSGENIC MICE
H. Schell et al.
NEUROSCIENCE (2009)
TAM Receptor Signalling and Demyelination
Michele D. Binder et al.
NEUROSIGNALS (2009)
Dopamine-Induced Conformational Changes in Alpha-Synuclein
Tiago F. Outeiro et al.
PLOS ONE (2009)
Animal models of Parkinson's disease progression
Gloria E. Meredith et al.
ACTA NEUROPATHOLOGICA (2008)
Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia
Joohyung Lee et al.
BRAIN (2008)
Microglial phagocytosis is enhanced by monomeric α-synuclein, not aggregated α-synuclein:: Implications for Parkinson's disease
Ji-Young Park et al.
GLIA (2008)
The transcription factor Nrf2 is a therapeutic target against brain inflammation
Nadia G. Innamorato et al.
JOURNAL OF IMMUNOLOGY (2008)
Regulation of microglial phagocytosis and inflammatory gene expression by gas6 acting on the Axl/Mer family of tyrosine kinases
Christian Grommes et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells
Mi-Kyoung Kwak et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2007)
Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein
Wei Zhang et al.
GLIA (2007)
The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein -: implications for Parkinson's disease
Frank P. Marx et al.
FASEB JOURNAL (2007)
Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress - Relevance to Parkinson disease
Noriyuki Yamamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Expression of Nrf2 in neurodegenerative diseases
Chenere P. Ramsey et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice
Rong Hu et al.
CANCER LETTERS (2006)
Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray
Rong Hu et al.
LIFE SCIENCES (2006)
α-synuclein expression modulates microglial activation phenotype
Susan A. Austin et al.
JOURNAL OF NEUROSCIENCE (2006)
Nuclear localization of the 20S proteasome subunit in Parkinson's disease
Atsuko Nakamura et al.
NEUROSCIENCE LETTERS (2006)
Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression
Matthew Maingay et al.
NEUROBIOLOGY OF DISEASE (2006)
Increase of GAP-43 in the rat cerebellum following unilateral striatal 6-OHDA lesion
M Perovic et al.
SYNAPSE (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid
JH Suh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease
C Lo Bianco et al.
NEUROBIOLOGY OF DISEASE (2004)
Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors
D Kirik et al.
TRENDS IN NEUROSCIENCES (2003)
Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein:: A new primate model of Parkinson's disease
D Kirik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Altered proteasomal function in sporadic Parkinson's disease
KS McNaught et al.
EXPERIMENTAL NEUROLOGY (2003)
Impaired dopamine storage resulting from α-synuclein mutations may contribute to the pathogenesis of Parkinson's disease
J Lotharius et al.
HUMAN MOLECULAR GENETICS (2002)
Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer
D Kirik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector
B Georgievska et al.
NEUROREPORT (2002)
Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease
D Kirik et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Rat α-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex
M Ghee et al.
JOURNAL OF NEUROCHEMISTRY (2000)